Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 5, 2009, Pages 508.e1-508.e6

  Poon, Leona C Y ^a   Chelemen, Teodora ^a   Minekawa, Ryoko ^a   Frisova, Veronika ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

ADAM12 (A disintegrin and metalloprotease); aneuploidies; Down syndrome; first trimester; screening

Indexed keywords

ADAM 12 PROTEIN; ADAM PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME NUMBER; CONTROLLED STUDY; DIAGNOSTIC VALUE; EUPLOIDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING TEST; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME;

EID: 64249123581     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.12.029     Document Type: Article

References (14)

1. Laigaard J., Sørensen T., Fröhlich C., et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 23 (2003) 1086-1091
2. Laigaard J., Cuckle H., Wewer U.M., and Christiansen M. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation. Prenat Diagn 26 (2006) 689-691
3. Spencer K., Vereecken A., and Cowans N.J. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation. Prenat Diagn 28 (2008) 209-211
4. Spencer K., Cowans N.J., Uldbjerg N., and Tørring N. First-trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?. Prenat Diagn 28 (2008) 338-342
5. Spencer K., Cowans N.J., and Stamatopoulou A. Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21. Prenat Diagn 28 (2008) 422-424
6. Laigaard J., Spencer K., Christiansen M., et al. ADAM12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 26 (2006) 973-979
7. Spencer K., and Cowans N.J. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. J Matern Fetal Neonatal Med 20 (2007) 645-650
8. Spencer K., Cowans N.J., and Stamatopoulou A. Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy. Prenat Diagn 27 (2007) 1233-1237
9. Snijders R.M.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 351 (1998) 343-346
10. Nicolaides K.H., Spencer K., Avgidou K., Faiola S., and Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25 (2005) 221-226
11. Robinson H.P., and Fleming J.E. A critical evaluation of sonar crown-rump length measurements. BJOG 82 (1975) 702-710
12. Kagan K.O., Wright D., Spencer K., Molina F.S., and Nicolaides K.H. First-trimester screening for trisomy 21 by free β-hCG and PAPP-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31 (2008) 493-502
13. Christiansen M., Spencer K., Laigaard J., Cowans N.J., Larsen S.O., and Wewer U.M. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 27 (2007) 611-615
14. Kagan K.O., Wright D., Valencia C., Maiz N., and Nicolaides K.H. Screening for trisomies 21, 18 and 13 by maternal age, fetal NT, fetal heart rate, free β hCG and PAPP-A. Hum Reprod 23 (2008) 1968-1975